LICHEN SCLEROSUS OF VULVA
Clinical trials for LICHEN SCLEROSUS OF VULVA explained in plain language.
Never miss a new study
Get alerted when new LICHEN SCLEROSUS OF VULVA trials appear
Sign up with your email to follow new studies for LICHEN SCLEROSUS OF VULVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New biologic aims to quiet the itch of a chronic skin condition
Symptom relief Not yet recruitingThis phase 2 trial tests whether nemolizumab, an injectable biologic, can reduce severe itching in women with vulvar lichen sclerosus, a chronic inflammatory skin condition. Participants receive weight-based doses of the drug and track their itch scores daily. The study focuses o…
Matched conditions: LICHEN SCLEROSUS OF VULVA
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Hormone combo may offer new hope for vulvodynia sufferers
Symptom relief Not yet recruitingThis study tests whether a cream containing both testosterone and estrogen works better than estrogen alone to reduce pain during sex for women with vulvodynia. About 44 adult women with moderate to severe pain will use one of the two creams daily. The goal is to find a more effe…
Matched conditions: LICHEN SCLEROSUS OF VULVA
Phase: PHASE2, PHASE3 • Sponsor: TriHealth Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC